Activity of the anti-IGF-1R antibody dalotuzumab (MK-0646) in KRAS-mutant colorectal cancer: Preclinical and clinical data.
Sriram Sathyanarayanan
Employment or Leadership Position - Merck
Mark Ayers
Employment or Leadership Position - Merck
David Cunningham
Consultant or Advisory Role - Roche (U)
Research Funding - Amgen; AstraZeneca; Roche
Expert Testimony - Amgen (U)
Sabine Tejpar
No relevant relationships to disclose
Josep Tabernero
Consultant or Advisory Role - Merck
Honoraria - Merck
Research Funding - Merck
Eliza Anne Hawkes
No relevant relationships to disclose
Tae Won Kim
Research Funding - Merck
Tae-You Kim
Research Funding - Merck
Sun Young Kim
Research Funding - Merck
Andrey Loboda
Employment or Leadership Position - Merck
Michael Nebozhyn
Employment or Leadership Position - Merck
Robin Mogg
No relevant relationships to disclose
George Naumov
Employment or Leadership Position - Merck
Andrew Bloecher
Employment or Leadership Position - Merck
Erin Valentine
Employment or Leadership Position - Merck (U)
Holly M. Brown
Employment or Leadership Position - Merck (U)
David J. Watkins
No relevant relationships to disclose
David J. Mauro
Employment or Leadership Position - Merck